Investors Purchase High Volume of agilon health Call Options (NYSE:AGL)

agilon health, inc. (NYSE:AGL) saw some unusual options trading on Friday. Investors acquired 6,103 call options on the stock. This represents an increase of 471% compared to the typical volume of 1,069 call options.

Institutional Trading of agilon health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of agilon health by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after purchasing an additional 272,787 shares during the last quarter. Capital International Investors grew its holdings in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after purchasing an additional 9,346,295 shares during the last quarter. State Street Corp grew its holdings in shares of agilon health by 3.0% during the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Millennium Management LLC grew its holdings in shares of agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after purchasing an additional 4,706,357 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of agilon health by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after purchasing an additional 35,207 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on AGL. Macquarie started coverage on agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective for the company. Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a research report on Friday. Stifel Nicolaus boosted their price target on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday, February 26th. Sanford C. Bernstein boosted their price target on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. Finally, Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and boosted their price target for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $3.95.

agilon health Stock Up 6.2 %

Shares of AGL traded up $0.26 during midday trading on Friday, reaching $4.36. 3,365,968 shares of the company were exchanged, compared to its average volume of 4,613,849. The stock has a 50-day moving average price of $3.47 and a 200-day moving average price of $2.95. The company has a market cap of $1.80 billion, a price-to-earnings ratio of -4.64 and a beta of 0.67. agilon health has a 1-year low of $1.50 and a 1-year high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.